Article
Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types: A Real-World Evidence Evaluation.
The Journal of molecular diagnostics : JMD - 1 Apr 2024
Ferreira-Gonzalez Andrea, Hocum Brian, Ko Gilbert, Shuvo Sohul, Appukkuttan Sreevalsa, Babajanyan Svetlana
Abstract excerpt
There are limited data on the prevalence of next-generation sequencing (NGS) in the United States, especially in light of the increasing importance of identifying actionable oncogenic variants due to molecular biomarker-based therapy approvals. This retrospective study of adult patients with select metastatic solid tumors and central nervous system tumors from the Optum Clinformatics Data Mart US health care...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
